| dc.contributor.author | Krol, Alexandra | |
| dc.contributor.author | Lopez Huerta, Violeta | |
| dc.contributor.author | Corey, Taylor E. C. | |
| dc.contributor.author | Deisseroth, Karl | |
| dc.contributor.author | Ting, Jonathan Thomas | |
| dc.contributor.author | Feng, Guoping | |
| dc.date.accessioned | 2020-08-17T21:03:27Z | |
| dc.date.available | 2020-08-17T21:03:27Z | |
| dc.date.issued | 2019-02 | |
| dc.identifier.issn | 1662-5110 | |
| dc.identifier.uri | https://hdl.handle.net/1721.1/126636 | |
| dc.description.abstract | Dopaminergic and serotonergic neurons modulate and control processes ranging from reward signaling to regulation of motor outputs. Further, dysfunction of these neurons is involved in both degenerative and psychiatric disorders. Elucidating the roles of these neurons has been greatly facilitated by bacterial artificial chromosome (BAC) transgenic mouse lines expressing channelrhodopsin to readily enable cell-type specific activation. However, corresponding lines to silence these monoaminergic neurons have been lacking. We have generated two BAC transgenic mouse lines expressing the outward proton pump, enhanced ArchT3.0 (eArchT3.0), and GFP under control of the regulatory elements of either the dopamine transporter (DAT; Jax# 031663) or the tryptophan hydroxylase 2 (TPH2; Jax# 031662) gene locus. We demonstrate highly faithful and specific expression of these lines in dopaminergic and serotonergic neurons respectively. Additionally we validate effective and sensitive eArchT3.0-mediated silencing of these neurons using slice electrophysiology as well as with a well-established behavioral assay. These new transgenic tools will help expedite the study of dopaminergic and serotonergic system function in normal behavior and disease. | en_US |
| dc.description.sponsorship | National Institute of Neurological Disorders and Stroke (Grants R01NS098505 and R21NS079992) | en_US |
| dc.description.sponsorship | Simons Foundation (Grant 307913) | en_US |
| dc.description.sponsorship | National Institute of Mental Health (Grant R01MH099647) | en_US |
| dc.description.sponsorship | National Institute on Drug Abuse (Grant P50DA042012) | en_US |
| dc.description.sponsorship | Defense Sciences Office (Contract W911NF-14-2-0013) | en_US |
| dc.language.iso | en | |
| dc.publisher | Frontiers Media SA | en_US |
| dc.relation.isversionof | http://dx.doi.org/10.3389/fncir.2019.00004 | en_US |
| dc.rights | Creative Commons Attribution 4.0 International license | en_US |
| dc.rights.uri | https://creativecommons.org/licenses/by/4.0/ | en_US |
| dc.source | Frontiers | en_US |
| dc.title | Two eARCHT3.0 Lines for Optogenetic Silencing of Dopaminergic and Serotonergic Neurons | en_US |
| dc.type | Article | en_US |
| dc.identifier.citation | Krol, Alexandra et al. "Two eARCHT3.0 Lines for Optogenetic Silencing of Dopaminergic and Serotonergic Neurons." Frontiers in Neural Circuits 13 (February 2019): 4 dx.doi.org/10.3389/fncir.2019.00004 © 2019 The Author(s) | en_US |
| dc.contributor.department | McGovern Institute for Brain Research at MIT | en_US |
| dc.contributor.department | Massachusetts Institute of Technology. Department of Brain and Cognitive Sciences | en_US |
| dc.relation.journal | Frontiers in Neural Circuits | en_US |
| dc.eprint.version | Final published version | en_US |
| dc.type.uri | http://purl.org/eprint/type/JournalArticle | en_US |
| eprint.status | http://purl.org/eprint/status/PeerReviewed | en_US |
| dc.date.updated | 2019-10-01T12:47:15Z | |
| dspace.date.submission | 2019-10-01T12:47:20Z | |
| mit.journal.volume | 13 | en_US |
| mit.metadata.status | Complete | |